BioHiTech Global, Inc., through its subsidiaries, provides technological, biological, and mechanical engineering solutions of organic and municipal waste worldwide.
BioHiTech Global Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$1.32|
|52 Week High||US$1.10|
|52 Week Low||US$4.03|
|1 Month Change||-10.20%|
|3 Month Change||-6.38%|
|1 Year Change||7.32%|
|3 Year Change||-54.64%|
|5 Year Change||-58.75%|
|Change since IPO||-70.67%|
Recent News & Updates
BioHiTech Global, Inc. (NASDAQ:BHTG) Shares Could Be 48% Below Their Intrinsic Value Estimate
How far off is BioHiTech Global, Inc. ( NASDAQ:BHTG ) from its intrinsic value? Using the most recent financial data...
BioHiTech Global signs project management pact with Lone Cypress Energy
BioHiTech Global (BHTG) has entered into a project management services agreement with Lone Cypress Energy Services to evaluate and develop new High-Efficiency Biological Treatment projects.The two companies will also explore additional uses of solid recovered fuel and other potential fuels that could be developed.Under the pact, Lone Cypress will take a lead role in environmental permitting and regulatory compliance services related to the development of additional patented HEBioT facilities and in the renewable energy business sector.Further, both parties are also
|BHTG||US Commercial Services||US Market|
Return vs Industry: BHTG underperformed the US Commercial Services industry which returned 26.9% over the past year.
Return vs Market: BHTG underperformed the US Market which returned 30% over the past year.
Stable Share Price: BHTG is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: BHTG's weekly volatility has decreased from 13% to 7% over the past year.
About the Company
BioHiTech Global, Inc., through its subsidiaries, provides technological, biological, and mechanical engineering solutions of organic and municipal waste worldwide. Its suite of technologies includes on-site biological processing equipment for food waste, patented processing facilities for the conversion of municipal solid waste into renewable fuel, and proprietary real-time data analytics tools to reduce food waste generation. The company also markets Revolution Series Digesters, an aerobic digestion technology solution for the disposal of food waste at the point of generation; and High Efficiency Biological Treatment Resource Recovery Technology to process waste at the municipal or enterprise level.
BioHiTech Global Fundamentals Summary
|BHTG fundamental statistics|
Is BHTG overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BHTG income statement (TTM)|
|Cost of Revenue||US$8.41m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.38|
|Net Profit Margin||-113.93%|
How did BHTG perform over the long term?See historical performance and comparison
Is BioHiTech Global undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: BHTG ($1.32) is trading below our estimate of fair value ($3.21)
Significantly Below Fair Value: BHTG is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: BHTG is unprofitable, so we can't compare its PE Ratio to the US Commercial Services industry average.
PE vs Market: BHTG is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate BHTG's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: BHTG is overvalued based on its PB Ratio (57x) compared to the US Commercial Services industry average (2.5x).
How is BioHiTech Global forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BHTG is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BHTG is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BHTG is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BHTG's revenue (31% per year) is forecast to grow faster than the US market (9.9% per year).
High Growth Revenue: BHTG's revenue (31% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BHTG's Return on Equity is forecast to be high in 3 years time
How has BioHiTech Global performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: BHTG is currently unprofitable.
Growing Profit Margin: BHTG is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: BHTG is unprofitable, and losses have increased over the past 5 years at a rate of 8.2% per year.
Accelerating Growth: Unable to compare BHTG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BHTG is unprofitable, making it difficult to compare its past year earnings growth to the Commercial Services industry (33.8%).
Return on Equity
High ROE: BHTG has a negative Return on Equity (-190.67%), as it is currently unprofitable.
How is BioHiTech Global's financial position?
Financial Position Analysis
Short Term Liabilities: BHTG's short term assets ($9.6M) do not cover its short term liabilities ($18.7M).
Long Term Liabilities: BHTG's short term assets ($9.6M) do not cover its long term liabilities ($32.4M).
Debt to Equity History and Analysis
Debt Level: BHTG's debt to equity ratio (535.2%) is considered high.
Reducing Debt: BHTG had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BHTG has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if BHTG has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is BioHiTech Global current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate BHTG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BHTG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if BHTG's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BHTG's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of BHTG's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Tony Fuller (63 yo)
Mr. Anthony Fuller, also known as Tony, has been the Chief Executive Officer of BioHiTech Global, Inc. since November 5, 2020 and served as its Chief Administrative Officer since March 2020 until November...
CEO Compensation Analysis
Compensation vs Market: Tony's total compensation ($USD162.20K) is below average for companies of similar size in the US market ($USD545.22K).
Compensation vs Earnings: Tony's compensation has increased whilst the company is unprofitable.
Experienced Management: BHTG's management team is considered experienced (3.8 years average tenure).
Experienced Board: BHTG's board of directors are considered experienced (5.4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.6%.
BioHiTech Global, Inc.'s employee growth, exchange listings and data sources
- Name: BioHiTech Global, Inc.
- Ticker: BHTG
- Exchange: NasdaqCM
- Founded: NaN
- Industry: Environmental and Facilities Services
- Sector: Commercial Services
- Market Cap: US$38.323m
- Shares outstanding: 29.03m
- Website: https://www.biohitech.com
Number of Employees
- BioHiTech Global, Inc.
- 80 Red Schoolhouse Road
- Suite 101
- Chestnut Ridge
- New York
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/19 23:50|
|End of Day Share Price||2021/10/19 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.